News IBM Watson impresses in brain tumour analysis Watson for Genomics produces treatment insights for glioblastoma in 10 minutes.
News Head patch device Optune improves brain cancer survival Median overall survival improved from 15 months to 21 months when combined with chemotherapy.
Views & Analysis Digital Health Round-up - Is AI the future of cancer drug de... Does artificial intelligence hold the key to cancer drug R&D?
News BERG begins trial for AI-engineered brain cancer drug Drug will be tested as a monotherapy for glioblastoma multiforme.
News Electrical patch device shows promise against ovarian cancer Novocure's Optune device shown to be safe and tolerable in recurrent ovarian cancer.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
